Dyne Therapeutics (DYN) earnings, Nov 5, 2026: EPS −39%, stock −6.4%
In brief
Dyne Therapeutics reported on Nov 5, 2026. Earnings per share changed −39% year over year, 16.8% below the estimate; revenue 0%. The stock opened with a +1.3% gap and closed the day −6.4% (Nov 5, 2026). The stock is now 36.4% below its 52-week high, −16.9% over 12 months.
EPS vs estimate−16.8%
EPS, YoY−39%
Revenue, YoY0%
Gap · day+1.3% · −6.4%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 29, 2026 | −2.4% | +2.5% |
| Nov 5, 2026 | +1.3% | −6.4% |
Next-quarter estimates, ratings and the DYN chart are in the terminal.
Open the terminalFAQ
When is Dyne Therapeutics's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did Dyne Therapeutics stock react to the report?
Opening gap +1.3%, day's result −6.4%.
Did Dyne Therapeutics's earnings grow?
Earnings per share fell 39% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.